Webinar: Company/University Interactions, July 6, 2024

2011 June 29
by Prentiss Riddle

The NCET2 Faculty Entrepreneur Webinar Series presents:

“Two Perspectives on Company/University Interactions Towards Research Commercialization and Innovation”

Wednesday, July 6, 2011, 1:00pm to 2:30pm EDT (18h00 to 19h30 Portugal time)

The NCET2 Faculty Entrepreneur Webinar Series allows faculty entrepreneurs a venue to share research commercialization know-how with their peers. Each month 2 or 3 faculty entrepreneurs talk about their startup/SBIR experiences to an audience of science and technology (S&T) faculty and students.

More information
Registration

Presenters:

Terrence Boult, PhD
El Palomar Endowed Professor of Innovation and Security
University of Colorado in Colorado Springs

Gabriel Gruionu, PhD
Research Fellow, Edwin L. Steele Laboratory for Tumor Biology
Department of Radiation Oncology, Harvard Medical School
Massachusetts General Hospital

Dr. Boult will discuss a Win-Win-Win model for student and faculty involvement in Small Business Innovative Research. This talk will discuss our experiences in incorporating students, both undergraduate and graduate students, into the SBIR/STTR process. We briefly review UCCS’s status and programs to put this work in context — and any why almost any NCET2 university should be able to leverage our models. The talk will review the processes used to help prepare students and the processes used to manage interaction with different types of companies. We review 3 different models of company-student-SBIR interactions that have all been successful. We will then discuss some of the student/learning outcomes (Win #1) and the business outcomes (Win #2) and the impact on the other stakeholders (Win #3, university and the community and sponsors).

Dr. Gruionu will present/discuss his personal experience with academic research commercialization and medical product industry. He will begin by talking about his experience as a postdoctoral fellow at the University of Arizona participating in industry-sponsored research projects. Next, as a product specialist for the Medical Product Division of W. L. Gore and Associates, Inc., Dr. Gruionu managed the “fitness-for-use” of both R&D and commercialized products, a unique opportunity that Gore offers Ph.D. scientists. As a member of the Board of Directors of the Biomedical Engineering Society, Dr. Gruionu organized two full day workshops during the annual BMES meetings about the collaboration between academia, industry, and clinicians for medical innovation where key opinion leaders from all three communities talked about the strengths and weaknesses of research commercialization and best practices across the country. He will also share his experience with starting his own medical product consulting company and his recent involvement with SBIR proposals. Finally, Dr. Gruionu will present general conclusions about research commercialization, and opportunities for postdocs and young faculty to get involved in the process.

COST OF THE WEBINAR: Free, but registration is required.

HOW TO PARTICIPATE?: This series is online. You need a computer with web access for the visual/audio. Q&A is conducted by a chat box to the speakers. Once registered to the webinar series you will receive a separate email with the webinar url 24 hours before the start of the webinar.

WHO SHOULD PARTICIPATE IN THE WEBINAR?: Entrepreneurial faculty, students, and postdocs; Technology Commercialization Officers and their staff; Chief operating or executive officers of university startup companies; university administrators seeking to enhance innovation and impact; and any one else interested in how faculty and universities participate in the innovation economy.

For more information about this webinar visit ncet2.org or contact [email protected].